US8450333B2ExpiredUtilityA1

Molecules for regulating cell death

Assignee: NUNNARI JODIPriority: Jun 9, 2003Filed: Feb 8, 2008Granted: May 28, 2013
Est. expiryJun 9, 2023(expired)· nominal 20-yr term from priority
C07D 277/36C07D 513/04C07D 277/38C07D 498/04C07D 409/14C07D 239/95
78
PatentIndex Score
9
Cited by
8
References
12
Claims

Abstract

The present invention provides compounds capable of regulating apoptosis, e.g., via regulating mitochondrial fission or fusion. The present invention also provides methods of screening for compounds capable of regulating apoptosis and methods of treating conditions association with apoptosis.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method of inhibiting mitochondrial fission in mammalian cells comprising contacting the cells with a compound of the general formula: 
       
         
           
           
               
               
           
         
         wherein R 1  is independently H; a C1-C18 alkyl or C1-C18 heteroalkyl, which may be branched, may be substituted, or combinations thereof; a C1-C18 alkenyl or C1-C18heteroalkenyl, which may be branched, may be substituted, or combinations thereof; a C1-C18alkynyl or C1-C18 heteroalkynyl, which may be branched, may be substituted, or combinations thereof; a C3-C18 aryl or C3-C18 heteroaryl, which may contain a bridge, may be substituted, or combinations thereof; or a C5-C18 cycloalkyl or C5-C18 heterocycle, which may contain a bridge, may be substituted, or combinations thereof; 
         R 2  is H; a C1-C18 alkyl or C1-C18 heteroalkyl, which may be branched, may be substituted, or combinations thereof; or a halogen; 
         R 3  is H; a C1-C18 alkyl or C1-C18 heteroalkyl, which may be branched, or may be substituted, or combinations thereof; 
         R 4  is a halogen; and 
         R 5  is a halogen, 
         thereby inhibiting mitochondrial fission in the mammalian cells. 
       
     
     
       2. The method of  claim 1 , wherein R 3  is a C1 heteroalkyl. 
     
     
       3. The method of  claim 1 , wherein R 3  is a C3 heteroalkyl. 
     
     
       4. The method of  claim 2 , wherein R 2  is H. 
     
     
       5. The method of  claim 3 , wherein R 2  is H. 
     
     
       6. The method of  claim 3 , wherein R 1  is independently selected from H or a C1-C18 alkyl. 
     
     
       7. The method of  claim 4 , wherein R 1  is H. 
     
     
       8. The method of  claim 4 , wherein R 1  is a C1 alkyl. 
     
     
       9. The method of  claim 5 , wherein R 1  is H. 
     
     
       10. The method of  claim 4 , wherein the compound is defined by the structure: 
       
         
           
           
               
               
           
         
       
     
     
       11. A method of inhibiting mitochondrial fission in mammalian cells comprising contacting the cells with a compound defined as 2-mercapto-3-(2-(trifluoromethyl)phenyl)quinazolin-4(3H)one, thereby inhibiting mitochondrial fission in the mammalian cells. 
     
     
       12. A method of inhibiting apoptosis in cells comprising contacting the cells with a compound of the general formula: 
       
         
           
           
               
               
           
         
         wherein R 1  is independently H; a C1-C18 alkyl or C1-C18 heteroalkyl, which may be branched, may be substituted, or combinations thereof; a C1-C18 alkenyl or C1-C18heteroalkenyl, which may be branched, may be substituted, or combinations thereof; a C1-C 18alkynyl or C1-C18 heteroalkynyl, which may be branched, may be substituted, or combinations thereof; a C3-C18 aryl or C3-C18 heteroaryl, which may contain a bridge, may be substituted, or combinations thereof; or a C5-C18 cycloalkyl or C5-C18 heterocycle, which may contain a bridge, may be substituted, or combinations thereof; 
         R 2  is H; a C1-C18 alkyl or C1-C18 heteroalkyl, which may be branched, may be substituted, or combinations thereof; or a halogen; 
         R 3  is H; a C1-C18 alkyl or C1-C18 heteroalkyl, which may be branched, or may be substituted, or combinations thereof; 
         R 4  is a halogen; and 
         R 5  is a halogen, 
         thereby inhibiting apoptosis in the cells.

Join the waitlist — get patent alerts

Track US8450333B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.